Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DreaMS - Development of Digital Biomarkers in Multiple Sclerosis - Feasibility Study

NCT04413032 is registered in ClinicalTrials.gov with Research Center for Clinical Neuroimmunology and Neuroscience Basel as lead sponsor.

NCT NCT04413032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04413032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DreaMS - Development of Digital Biomarkers in Multiple Sclerosis - Feasibility Study
Lead sponsor
Research Center for Clinical Neuroimmunology and Neuroscience Basel
Phase
Not applicable
Overall status
Completed
Start date
October 5, 2020
Completion date
February 26, 2021
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis